Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Outlook For 2026–2030 Covering Growth Drivers And Industry Trends
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market From 2026 To 2030?
The chronic obstructive pulmonary disease (copd) and asthma devices market has demonstrated significant growth in recent years. This market is anticipated to expand from $47.56 billion in 2025 to $50.3 billion by 2026, reflecting a compound annual growth rate (CAGR) of 5.8%. Historically, this expansion has been driven by elements such as the rising prevalence of asthma and COPD, increased air pollution and smoking rates, the growing utilization of inhalation therapy, the expansion of respiratory care services, and improvements in the diagnosis of chronic respiratory diseases.
The chronic obstructive pulmonary disease (copd) and asthma devices market is set to experience robust growth in the upcoming years, with its size projected to reach $62.83 billion by 2030, achieving a compound annual growth rate (CAGR) of 5.7%. This expansion throughout the forecast period can be attributed to an aging population facing elevated respiratory risks, an escalating demand for at-home respiratory devices, heightened awareness regarding the early management of respiratory illnesses, the proliferation of chronic disease management programs, and enhanced access to respiratory care across emerging markets. Significant trends during this period are expected to involve the increased adoption of home-based respiratory care equipment, a growing preference for portable and user-friendly inhalation devices, an intensified focus on solutions for long-term disease management, broader utilization of these devices among both pediatric and geriatric populations, and a greater emphasis on treatment adherence and symptom control.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp
Which Important Drivers Are Guiding The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Growth?
The increasing incidence of respiratory ailments is anticipated to fuel the expansion of the chronic obstructive pulmonary disease (COPD) and asthma devices market moving ahead. These diseases cover a broad spectrum of conditions impacting the lungs and respiratory systems, including asthma, chronic obstructive pulmonary disease, pneumonia, and lung cancer, which hinder normal breathing and general respiratory function. This rise in respiratory disease prevalence stems from escalating air pollution levels, shifting climatic patterns that influence allergens and pathogens, and lifestyle choices like smoking, all of which impair respiratory well-being. Devices for COPD and asthma are vital for the thorough management and treatment of these conditions, helping patients attain improved respiratory health and boost their overall quality of life. For example, data from December 2023, provided by the National Center for Biotechnology Information, a US-based government body, projected a surge in COPD cases by 112 million, reaching 592 million by 2050, which would constitute 9.5% of the eligible population. Consequently, the increasing occurrence of respiratory illnesses acts as a key driver for the expansion of the chronic obstructive pulmonary disease (COPD) and asthma devices markets.
What Are The Main Segments Within The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Segment Structure?
The chronic obstructive pulmonary disease (copd) and asthma devices market covered in this report is segmented –
1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric
Subsegments:
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories, Spacer Devices
What Trends Are Influencing The Evolution Of The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Leading companies within the chronic obstructive pulmonary disease and asthma devices market are concentrating on developing advanced solutions, such as intelligent, sensor-equipped inhaler technologies. These innovations aim to enhance medication adherence, enable real-time tracking of symptoms, and support personalized management of respiratory conditions. Such smart inhaler technologies incorporate integrated sensors and digital connectivity features to capture inhalation data, monitor patient usage patterns, and deliver practical insights to both individuals and medical professionals. As an illustration, in July 2023, Teva UK Ltd., a UK-based pharmaceutical company, introduced the GoResp Digihaler. This digitally connected inhaler is engineered to log inhalation parameters, offer immediate feedback, and contribute to better disease management through patient engagement driven by data. The device helps improve treatment outcomes by facilitating remote observation, granting clinicians greater visibility into patient adherence trends, and reinforcing the sustained management of chronic respiratory conditions for affected individuals.
Who Are The Companies Participating In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Major companies operating in the chronic obstructive pulmonary disease (copd) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Omron Corporation, Smiths Medical Inc., Cipla Ltd., Chiesi Farmaceutici SpA, Sunovion Pharmaceuticals Inc., Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd., 3M Health Care, Vyaire Medical Inc., Aerogen Ltd
Get The Full Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report:
Where Is The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Most Concentrated Geographically?
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2025. The regions covered in the chronic obstructive pulmonary disease (copd) and asthma devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=18298&type=smp
Browse Through More Reports Similar to the Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market 2026, By The Business Research Company
High Performance Liquid Chromatography Market Report 2026
Analytical Laboratory Instrument Market Report 2026
Chromatography Software Market Report 2026
https://www.thebusinessresearchcompany.com/report/chromatography-software-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
